[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Live Attenuated Vaccines Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

August 2023 | 111 pages | ID: GEDE73657DD7EN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Live Attenuated Vaccines market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Live Attenuated Vaccines market are covered in Chapter 9:

Merck & Co.
Serum Institute of India Pvt. Ltd.
Sanofi
Emergent BioSolutions, Inc.
GlaxoSmithKline, plc.
Astellas Pharma Inc.
CSL Limited
MedImmune, LLC
Pfizer, Inc.
Johnson & Johnson

In Chapter 5 and Chapter 7.3, based on types, the Live Attenuated Vaccines market from 2017 to 2027 is primarily split into:

Bacterial
Viral

In Chapter 6 and Chapter 7.4, based on applications, the Live Attenuated Vaccines market from 2017 to 2027 covers:

Hospitals
Clinics
Diagnostic Centers
Research Institute
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa

Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Live Attenuated Vaccines market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Live Attenuated Vaccines Industry.

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in Summary.

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline

Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:

Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 LIVE ATTENUATED VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Live Attenuated Vaccines Market
1.2 Live Attenuated Vaccines Market Segment by Type
  1.2.1 Global Live Attenuated Vaccines Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Live Attenuated Vaccines Market Segment by Application
  1.3.1 Live Attenuated Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Live Attenuated Vaccines Market, Region Wise (2017-2027)
  1.4.1 Global Live Attenuated Vaccines Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Live Attenuated Vaccines Market Status and Prospect (2017-2027)
  1.4.3 Europe Live Attenuated Vaccines Market Status and Prospect (2017-2027)
  1.4.4 China Live Attenuated Vaccines Market Status and Prospect (2017-2027)
  1.4.5 Japan Live Attenuated Vaccines Market Status and Prospect (2017-2027)
  1.4.6 India Live Attenuated Vaccines Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Live Attenuated Vaccines Market Status and Prospect (2017-2027)
  1.4.8 Latin America Live Attenuated Vaccines Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Live Attenuated Vaccines Market Status and Prospect (2017-2027)
1.5 Global Market Size of Live Attenuated Vaccines (2017-2027)
  1.5.1 Global Live Attenuated Vaccines Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Live Attenuated Vaccines Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Live Attenuated Vaccines Market

2 INDUSTRY OUTLOOK

2.1 Live Attenuated Vaccines Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Live Attenuated Vaccines Market Drivers Analysis
2.4 Live Attenuated Vaccines Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Live Attenuated Vaccines Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Live Attenuated Vaccines Industry Development

3 GLOBAL LIVE ATTENUATED VACCINES MARKET LANDSCAPE BY PLAYER

3.1 Global Live Attenuated Vaccines Sales Volume and Share by Player (2017-2022)
3.2 Global Live Attenuated Vaccines Revenue and Market Share by Player (2017-2022)
3.3 Global Live Attenuated Vaccines Average Price by Player (2017-2022)
3.4 Global Live Attenuated Vaccines Gross Margin by Player (2017-2022)
3.5 Live Attenuated Vaccines Market Competitive Situation and Trends
  3.5.1 Live Attenuated Vaccines Market Concentration Rate
  3.5.2 Live Attenuated Vaccines Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL LIVE ATTENUATED VACCINES SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Live Attenuated Vaccines Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Live Attenuated Vaccines Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Live Attenuated Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Live Attenuated Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Live Attenuated Vaccines Market Under COVID-19
4.5 Europe Live Attenuated Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Live Attenuated Vaccines Market Under COVID-19
4.6 China Live Attenuated Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Live Attenuated Vaccines Market Under COVID-19
4.7 Japan Live Attenuated Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Live Attenuated Vaccines Market Under COVID-19
4.8 India Live Attenuated Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Live Attenuated Vaccines Market Under COVID-19
4.9 Southeast Asia Live Attenuated Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Live Attenuated Vaccines Market Under COVID-19
4.10 Latin America Live Attenuated Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Live Attenuated Vaccines Market Under COVID-19
4.11 Middle East and Africa Live Attenuated Vaccines Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Live Attenuated Vaccines Market Under COVID-19

5 GLOBAL LIVE ATTENUATED VACCINES SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Live Attenuated Vaccines Sales Volume and Market Share by Type (2017-2022)
5.2 Global Live Attenuated Vaccines Revenue and Market Share by Type (2017-2022)
5.3 Global Live Attenuated Vaccines Price by Type (2017-2022)
5.4 Global Live Attenuated Vaccines Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Live Attenuated Vaccines Sales Volume, Revenue and Growth Rate of Bacterial (2017-2022)
  5.4.2 Global Live Attenuated Vaccines Sales Volume, Revenue and Growth Rate of Viral (2017-2022)

6 GLOBAL LIVE ATTENUATED VACCINES MARKET ANALYSIS BY APPLICATION

6.1 Global Live Attenuated Vaccines Consumption and Market Share by Application (2017-2022)
6.2 Global Live Attenuated Vaccines Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Live Attenuated Vaccines Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Live Attenuated Vaccines Consumption and Growth Rate of Hospitals (2017-2022)
  6.3.2 Global Live Attenuated Vaccines Consumption and Growth Rate of Clinics (2017-2022)
  6.3.3 Global Live Attenuated Vaccines Consumption and Growth Rate of Diagnostic Centers (2017-2022)
  6.3.4 Global Live Attenuated Vaccines Consumption and Growth Rate of Research Institute (2017-2022)
  6.3.5 Global Live Attenuated Vaccines Consumption and Growth Rate of Others (2017-2022)

7 GLOBAL LIVE ATTENUATED VACCINES MARKET FORECAST (2022-2027)

7.1 Global Live Attenuated Vaccines Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Live Attenuated Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Live Attenuated Vaccines Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Live Attenuated Vaccines Price and Trend Forecast (2022-2027)
7.2 Global Live Attenuated Vaccines Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Live Attenuated Vaccines Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Live Attenuated Vaccines Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Live Attenuated Vaccines Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Live Attenuated Vaccines Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Live Attenuated Vaccines Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Live Attenuated Vaccines Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Live Attenuated Vaccines Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Live Attenuated Vaccines Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Live Attenuated Vaccines Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Live Attenuated Vaccines Revenue and Growth Rate of Bacterial (2022-2027)
  7.3.2 Global Live Attenuated Vaccines Revenue and Growth Rate of Viral (2022-2027)
7.4 Global Live Attenuated Vaccines Consumption Forecast by Application (2022-2027)
  7.4.1 Global Live Attenuated Vaccines Consumption Value and Growth Rate of Hospitals(2022-2027)
  7.4.2 Global Live Attenuated Vaccines Consumption Value and Growth Rate of Clinics(2022-2027)
  7.4.3 Global Live Attenuated Vaccines Consumption Value and Growth Rate of Diagnostic Centers(2022-2027)
  7.4.4 Global Live Attenuated Vaccines Consumption Value and Growth Rate of Research Institute(2022-2027)
  7.4.5 Global Live Attenuated Vaccines Consumption Value and Growth Rate of Others(2022-2027)
7.5 Live Attenuated Vaccines Market Forecast Under COVID-19

8 LIVE ATTENUATED VACCINES MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Live Attenuated Vaccines Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Live Attenuated Vaccines Analysis
8.6 Major Downstream Buyers of Live Attenuated Vaccines Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Live Attenuated Vaccines Industry

9 PLAYERS PROFILES

9.1 Merck & Co.
  9.1.1 Merck & Co. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Live Attenuated Vaccines Product Profiles, Application and Specification
  9.1.3 Merck & Co. Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Serum Institute of India Pvt. Ltd.
  9.2.1 Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Live Attenuated Vaccines Product Profiles, Application and Specification
  9.2.3 Serum Institute of India Pvt. Ltd. Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Sanofi
  9.3.1 Sanofi Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Live Attenuated Vaccines Product Profiles, Application and Specification
  9.3.3 Sanofi Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Emergent BioSolutions, Inc.
  9.4.1 Emergent BioSolutions, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Live Attenuated Vaccines Product Profiles, Application and Specification
  9.4.3 Emergent BioSolutions, Inc. Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 GlaxoSmithKline, plc.
  9.5.1 GlaxoSmithKline, plc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Live Attenuated Vaccines Product Profiles, Application and Specification
  9.5.3 GlaxoSmithKline, plc. Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Astellas Pharma Inc.
  9.6.1 Astellas Pharma Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Live Attenuated Vaccines Product Profiles, Application and Specification
  9.6.3 Astellas Pharma Inc. Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 CSL Limited
  9.7.1 CSL Limited Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Live Attenuated Vaccines Product Profiles, Application and Specification
  9.7.3 CSL Limited Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 MedImmune, LLC
  9.8.1 MedImmune, LLC Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Live Attenuated Vaccines Product Profiles, Application and Specification
  9.8.3 MedImmune, LLC Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Pfizer, Inc.
  9.9.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Live Attenuated Vaccines Product Profiles, Application and Specification
  9.9.3 Pfizer, Inc. Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 Johnson & Johnson
  9.10.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Live Attenuated Vaccines Product Profiles, Application and Specification
  9.10.3 Johnson & Johnson Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES

Figure Live Attenuated Vaccines Product Picture
Table Global Live Attenuated Vaccines Market Sales Volume and CAGR (%) Comparison by Type
Table Live Attenuated Vaccines Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Live Attenuated Vaccines Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Live Attenuated Vaccines Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Live Attenuated Vaccines Industry Development
Table Global Live Attenuated Vaccines Sales Volume by Player (2017-2022)
Table Global Live Attenuated Vaccines Sales Volume Share by Player (2017-2022)
Figure Global Live Attenuated Vaccines Sales Volume Share by Player in 2021
Table Live Attenuated Vaccines Revenue (Million USD) by Player (2017-2022)
Table Live Attenuated Vaccines Revenue Market Share by Player (2017-2022)
Table Live Attenuated Vaccines Price by Player (2017-2022)
Table Live Attenuated Vaccines Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Live Attenuated Vaccines Sales Volume, Region Wise (2017-2022)
Table Global Live Attenuated Vaccines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Live Attenuated Vaccines Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Live Attenuated Vaccines Sales Volume Market Share, Region Wise in 2021
Table Global Live Attenuated Vaccines Revenue (Million USD), Region Wise (2017-2022)
Table Global Live Attenuated Vaccines Revenue Market Share, Region Wise (2017-2022)
Figure Global Live Attenuated Vaccines Revenue Market Share, Region Wise (2017-2022)
Figure Global Live Attenuated Vaccines Revenue Market Share, Region Wise in 2021
Table Global Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Live Attenuated Vaccines Sales Volume by Type (2017-2022)
Table Global Live Attenuated Vaccines Sales Volume Market Share by Type (2017-2022)
Figure Global Live Attenuated Vaccines Sales Volume Market Share by Type in 2021
Table Global Live Attenuated Vaccines Revenue (Million USD) by Type (2017-2022)
Table Global Live Attenuated Vaccines Revenue Market Share by Type (2017-2022)
Figure Global Live Attenuated Vaccines Revenue Market Share by Type in 2021
Table Live Attenuated Vaccines Price by Type (2017-2022)
Figure Global Live Attenuated Vaccines Sales Volume and Growth Rate of Bacterial (2017-2022)
Figure Global Live Attenuated Vaccines Revenue (Million USD) and Growth Rate of Bacterial (2017-2022)
Figure Global Live Attenuated Vaccines Sales Volume and Growth Rate of Viral (2017-2022)
Figure Global Live Attenuated Vaccines Revenue (Million USD) and Growth Rate of Viral (2017-2022)
Table Global Live Attenuated Vaccines Consumption by Application (2017-2022)
Table Global Live Attenuated Vaccines Consumption Market Share by Application (2017-2022)
Table Global Live Attenuated Vaccines Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Live Attenuated Vaccines Consumption Revenue Market Share by Application (2017-2022)
Table Global Live Attenuated Vaccines Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Live Attenuated Vaccines Consumption and Growth Rate of Clinics (2017-2022)
Table Global Live Attenuated Vaccines Consumption and Growth Rate of Diagnostic Centers (2017-2022)
Table Global Live Attenuated Vaccines Consumption and Growth Rate of Research Institute (2017-2022)
Table Global Live Attenuated Vaccines Consumption and Growth Rate of Others (2017-2022)
Figure Global Live Attenuated Vaccines Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Live Attenuated Vaccines Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Live Attenuated Vaccines Price and Trend Forecast (2022-2027)
Figure USA Live Attenuated Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Live Attenuated Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Live Attenuated Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Live Attenuated Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Live Attenuated Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Live Attenuated Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Live Attenuated Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Live Attenuated Vaccines Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Live Attenuated Vaccines Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Live Attenuated Vaccines Market Sales Volume Forecast, by Type
Table Global Live Attenuated Vaccines Sales Volume Market Share Forecast, by Type
Table Global Live Attenuated Vaccines Market Revenue (Million USD) Forecast, by Type
Table Global Live Attenuated Vaccines Revenue Market Share Forecast, by Type
Table Global Live Attenuated Vaccines Price Forecast, by Type
Figure Global Live Attenuated Vaccines Revenue (Million USD) and Growth Rate of Bacterial (2022-2027)
Figure Global Live Attenuated Vaccines Revenue (Million USD) and Growth Rate of Bacterial (2022-2027)
Figure Global Live Attenuated Vaccines Revenue (Million USD) and Growth Rate of Viral (2022-2027)
Figure Global Live Attenuated Vaccines Revenue (Million USD) and Growth Rate of Viral (2022-2027)
Table Global Live Attenuated Vaccines Market Consumption Forecast, by Application
Table Global Live Attenuated Vaccines Consumption Market Share Forecast, by Application
Table Global Live Attenuated Vaccines Market Revenue (Million USD) Forecast, by Application
Table Global Live Attenuated Vaccines Revenue Market Share Forecast, by Application
Figure Global Live Attenuated Vaccines Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Live Attenuated Vaccines Consumption Value (Million USD) and Growth Rate of Clinics (2022-2027)
Figure Global Live Attenuated Vaccines Consumption Value (Million USD) and Growth Rate of Diagnostic Centers (2022-2027)
Figure Global Live Attenuated Vaccines Consumption Value (Million USD) and Growth Rate of Research Institute (2022-2027)
Figure Global Live Attenuated Vaccines Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Live Attenuated Vaccines Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Merck & Co. Profile
Table Merck & Co. Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co. Live Attenuated Vaccines Sales Volume and Growth Rate
Figure Merck & Co. Revenue (Million USD) Market Share 2017-2022
Table Serum Institute of India Pvt. Ltd. Profile
Table Serum Institute of India Pvt. Ltd. Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Serum Institute of India Pvt. Ltd. Live Attenuated Vaccines Sales Volume and Growth Rate
Figure Serum Institute of India Pvt. Ltd. Revenue (Million USD) Market Share 2017-2022
Table Sanofi Profile
Table Sanofi Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Live Attenuated Vaccines Sales Volume and Growth Rate
Figure Sanofi Revenue (Million USD) Market Share 2017-2022
Table Emergent BioSolutions, Inc. Profile
Table Emergent BioSolutions, Inc. Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Emergent BioSolutions, Inc. Live Attenuated Vaccines Sales Volume and Growth Rate
Figure Emergent BioSolutions, Inc. Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline, plc. Profile
Table GlaxoSmithKline, plc. Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline, plc. Live Attenuated Vaccines Sales Volume and Growth Rate
Figure GlaxoSmithKline, plc. Revenue (Million USD) Market Share 2017-2022
Table Astellas Pharma Inc. Profile
Table Astellas Pharma Inc. Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Astellas Pharma Inc. Live Attenuated Vaccines Sales Volume and Growth Rate
Figure Astellas Pharma Inc. Revenue (Million USD) Market Share 2017-2022
Table CSL Limited Profile
Table CSL Limited Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CSL Limited Live Attenuated Vaccines Sales Volume and Growth Rate
Figure CSL Limited Revenue (Million USD) Market Share 2017-2022
Table MedImmune, LLC Profile
Table MedImmune, LLC Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure MedImmune, LLC Live Attenuated Vaccines Sales Volume and Growth Rate
Figure MedImmune, LLC Revenue (Million USD) Market Share 2017-2022
Table Pfizer, Inc. Profile
Table Pfizer, Inc. Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer, Inc. Live Attenuated Vaccines Sales Volume and Growth Rate
Figure Pfizer, Inc. Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Live Attenuated Vaccines Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Live Attenuated Vaccines Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022


More Publications